Shawn Egan

Stock Analyst at Citigroup

(2.02)
# 2,860
Out of 4,839 analysts
5
Total ratings
100%
Success rate
2.06%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Shawn Egan

Arrowhead Pharmaceuticals
May 13, 2025
Maintains: Neutral
Price Target: $21$17
Current: $15.16
Upside: +12.14%
OSZAR »